{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:49:15Z","timestamp":1791668955665,"version":"4.3.4"},"reference-count":175,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01005","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T04:19:00Z","timestamp":1503289140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":366,"title":["Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications"],"prefix":"10.3389","volume":"8","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neurol.2017.03.030","article-title":"Genetics of amyotrophic lateral sclerosis","volume":"173","author":"Corcia","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ejmech.2016.06.017","article-title":"Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning","volume":"121","author":"Kumar","year":"2016","journal-title":"Eur J Med Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1517\/14656566.2013.819344","article-title":"New therapy options for amyotrophic lateral sclerosis","volume":"14","author":"Gordon","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrneurol.2016.140","article-title":"Pathophysiological and diagnostic implications of cortical dysfunction in ALS","volume":"12","author":"Geevasinga","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg Neurol Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2849","DOI":"10.1371\/journal.pone.0002849","article-title":"Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS","volume":"3","author":"Chang","year":"2008","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.271.5248.515","article-title":"Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis","volume":"271","author":"Wiedau-Pazos","year":"1996","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.neuroscience.2010.06.018","article-title":"Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell","volume":"169","author":"Duan","year":"2010","journal-title":"Neuroscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1089\/ARS.2009.2604","article-title":"Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis","volume":"11","author":"Magrane","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/nen.0b013e31802c396b","article-title":"Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis","volume":"66","author":"Sasaki","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13901","DOI":"10.1073\/pnas.240305897","article-title":"Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis","volume":"97","author":"Pasinelli","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1113\/jphysiol.2012.247981","article-title":"Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"591","author":"Fuchs","year":"2013","journal-title":"J Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","article-title":"Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn-superoxide dismutase mutant mice","volume":"96","author":"Damiano","year":"2006","journal-title":"J Neurochem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/hmg\/dds011","article-title":"Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria","volume":"21","author":"M\u00f3rotz","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration"},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drudis.2014.08.016","article-title":"Neuroprotective agents target molecular mechanisms of disease in ALS","volume":"20","author":"Zhu","year":"2015","journal-title":"Drug Discov Today"},{"key":"B20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ana.410360608","article-title":"The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis","volume":"36","author":"Alexianu","year":"1994","journal-title":"Ann Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.neuint.2011.07.006","article-title":"Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors \u201cin vitro\u201d","volume":"59","author":"Texido","year":"2011","journal-title":"Neurochem Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/12227","article-title":"SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter","volume":"2","author":"Trotti","year":"1999","journal-title":"Nat Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.410390519","article-title":"Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex","volume":"39","author":"Bristol","year":"1996","journal-title":"Ann Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.2010.00417.x","article-title":"Reduction in the motoneuron inhibitory\/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Sunico","year":"2011","journal-title":"Brain Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","article-title":"Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"1998","journal-title":"Neuron"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","article-title":"Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice","volume":"12","author":"Guo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1385\/MN:21:1-2:083","article-title":"The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly","volume":"21","author":"Walker","year":"2000","journal-title":"Mol Neurobiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tins.2011.05.002","article-title":"TDP-43 and FUS: a nuclear affair","volume":"34","author":"Dormann","year":"2011","journal-title":"Trends Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.nbd.2011.08.031","article-title":"Mutant SOD1 forms ion channel: implications for ALS pathophysiology","volume":"45","author":"Allen","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/glia.22444","article-title":"Extracellular aggregated Cu\/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype","volume":"61","author":"Roberts","year":"2013","journal-title":"Glia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mcn.2016.01.012","article-title":"Autophagy in motor neuron disease: key pathogenetic mechanisms and therapeutic targets","volume":"72","author":"Cipolat Mis","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4161\/auto.5524","article-title":"Altered macroautophagy in the spinal cord of SOD1 mutant mice","volume":"4","author":"Li","year":"2008","journal-title":"Autophagy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/NEN.0b013e3182160690","article-title":"Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis","volume":"70","author":"Sasaki","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1101\/gad.1830709","article-title":"XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy","volume":"23","author":"Hetz","year":"2009","journal-title":"Genes Dev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.2174\/092986708785133031","article-title":"Biochemical markers in CSF of ALS patients","volume":"15","author":"S\u00fcssmuth","year":"2008","journal-title":"Curr Med Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5607\/en.2016.25.5.233","article-title":"Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Neurobiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1872214809666150407111420","article-title":"Is innate immunity and inflammasomes involved in pathogenesis of amyotrophic lateral sclerosis (ALS)?","volume":"9","author":"Volpe","year":"2015","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170615110446","article-title":"Targeting astrocytes for treatment in amyotrophic lateral sclerosis","author":"Peric","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","first-page":"537","article-title":"Neuroinflammation in motor neuron disease","volume":"77","author":"Komine","year":"2015","journal-title":"Nagoya J Med Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"B51","first-page":"4","article-title":"The microglial-motoneuron dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s00259-016-3311-y","article-title":"Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET\/CT","volume":"43","author":"Gargiulo","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e52941","DOI":"10.1371\/journal.pone.0052941","article-title":"Molecular imaging of microglial activation in amyotrophic lateral sclerosis","volume":"7","author":"Corcia","year":"2012","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O\u2019Rourke","year":"2016","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neuropharm.2015.10.026","article-title":"Purinergic contribution to amyotrophic lateral sclerosis","volume":"104","author":"Volont\u00e9","year":"2016","journal-title":"Neuropharmacology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","article-title":"The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis","volume":"183","author":"D\u2019Ambrosi","year":"2009","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-2094-7-33","article-title":"Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis","volume":"7","author":"Gandelman","year":"2010","journal-title":"J Neuroinflammation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.4049\/jimmunol.1203262","article-title":"The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis","volume":"190","author":"Apolloni","year":"2013","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","article-title":"Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Apolloni","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1242\/dmm.017038","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis Model Mech"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1021\/pr400376e","article-title":"Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry","volume":"12","author":"Blasco","year":"2013","journal-title":"J Proteome Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","article-title":"Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice","volume":"25","author":"Beers","year":"2011","journal-title":"Brain Behav Immun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","article-title":"Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis","volume":"121","author":"Forsberg","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-007-0285-7","article-title":"TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia","volume":"115","author":"Zhang","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"B71","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.stem.2008.09.017","article-title":"Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation","volume":"3","author":"Di Giorgio","year":"2008","journal-title":"Cell Stem Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat Neurosci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat Neurosci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nn.2210","article-title":"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease","volume":"11","author":"Lepore","year":"2008","journal-title":"Nat Neurosci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/hmg\/ddq463","article-title":"Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice","volume":"20","author":"Wang","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"17803","DOI":"10.1073\/pnas.1103141108","article-title":"Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo","volume":"108","author":"Papadeas","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B79","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.stemcr.2017.03.003","article-title":"Sporadic ALS astrocytes induce neuronal degeneration in vivo","volume":"8","author":"Qian","year":"2017","journal-title":"Stem Cell Reports"},{"key":"B80","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","article-title":"Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS","volume":"111","author":"Meyer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2006.03.028","article-title":"Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice","volume":"201","author":"Pardo","year":"2006","journal-title":"Exp Neurol"},{"key":"B82","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","article-title":"Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis","volume":"23","author":"Dunlop","year":"2003","journal-title":"J Neurosci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","article-title":"Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants","volume":"28","author":"Cassina","year":"2008","journal-title":"J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.stem.2008.10.001","article-title":"Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells","volume":"3","author":"Marchetto","year":"2008","journal-title":"Cell Stem Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1093\/brain\/awr193","article-title":"Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis","volume":"134","author":"Ferraiuolo","year":"2011","journal-title":"Brain"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-3-2","article-title":"Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation","volume":"3","author":"Hensley","year":"2006","journal-title":"J Neuroinflammation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","article-title":"Necroptosis drives motor neuron death in models of both sporadic and familial ALS","volume":"81","author":"Re","year":"2014","journal-title":"Neuron"},{"key":"B88","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1126\/science.aaf6803","article-title":"RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS","volume":"353","author":"Ito","year":"2016","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fncel.2013.00214","article-title":"Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis","volume":"7","author":"Bowerman","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B91","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"key":"B95","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","article-title":"T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis","volume":"148","author":"Saresella","year":"2013","journal-title":"Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0404.2010.01333.x","article-title":"Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17\u2009cells activation?","volume":"122","author":"Rentzos","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"B97","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-7-76","article-title":"IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients","volume":"7","author":"Fiala","year":"2010","journal-title":"J Neuroinflammation"},{"key":"B98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","article-title":"Alterations of T cell subsets in ALS: a systemic immune activation?","volume":"125","author":"Rentzos","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e22374","DOI":"10.1371\/journal.pone.0022374","article-title":"Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS","volume":"6","author":"Finkelstein","year":"2011","journal-title":"PLoS One"},{"key":"B100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","article-title":"Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process","volume":"210","author":"Mantovani","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-016-1548-y","article-title":"Peripheral monocytes are functionally altered and invade the CNS in ALS patients","volume":"132","author":"Zondler","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2016.89","article-title":"Impaired activation of ALS monocytes by exosomes","volume":"95","author":"Zondler","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","article-title":"Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes","volume":"74","author":"Zhao","year":"2017","journal-title":"JAMA Neurol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1212\/NXI.0000000000000242","article-title":"Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis","volume":"3","author":"Murdock","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B106","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2016.01.008","article-title":"Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)","volume":"277","author":"Van Dyke","year":"2016","journal-title":"Exp Neurol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-0-387-78952-1_11","article-title":"Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors","volume":"632","author":"Woodruff","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B113","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skelet Muscle"},{"key":"B114","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B115","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays disease onset and mortality in a transgenic model of ALS","volume":"13","author":"Van Den Bosch","year":"2002","journal-title":"Neuroreport"},{"key":"B118","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1212\/NXI.0000000000000100","article-title":"Randomized phase 2 trial of NP001-a novel immune regulator: safety and early efficacy in ALS","volume":"2","author":"Miller","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B121","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3109\/21678421.2014.951940","article-title":"NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study","volume":"15","author":"Miller","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B122","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-016-0620-9","article-title":"Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis","volume":"13","author":"Trias","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B123","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/13543784.2017.1302426","article-title":"Drugs in clinical development for the treatment of amyotrophic lateral sclerosis","volume":"26","author":"Martinez","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"B124","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","article-title":"Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Potenza","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0532-4","article-title":"Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis","author":"Crisafulli","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1517\/13543784.2014.933807","article-title":"Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs","volume":"23","author":"Goyal","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"B128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-016-0587-6","article-title":"Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS","volume":"13","author":"Rabinovich-Nikitin","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e0139684","DOI":"10.1371\/journal.pone.0139684","article-title":"Interleukin-1 antagonist anakinra in amyotrophic lateral sclerosis \u2013 a pilot study","volume":"10","author":"Maier","year":"2015","journal-title":"PLoS One"},{"key":"B130","first-page":"305","article-title":"Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling","volume":"1","author":"Mizwicki","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/17482960802709416","article-title":"Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial","volume":"10","author":"Stommel","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"B132","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.expneurol.2009.08.028","article-title":"Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis","volume":"220","author":"Neymotin","year":"2009","journal-title":"Exp Neurol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.20903","article-title":"Trial of celecoxib in amyotrophic lateral sclerosis","volume":"60","author":"Cudkowicz","year":"2006","journal-title":"Ann Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000090364","article-title":"Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis","volume":"2","author":"Kiaei","year":"2005","journal-title":"Neurodegener Dis"},{"key":"B135","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of dl-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.3760\/cma.j.issn.0366-6999.20123240","article-title":"Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial","volume":"126","author":"Cui","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3760\/cma.j.issn.0366-6999.2012.10.014","article-title":"Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"125","author":"Feng","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.neuropharm.2011.10.009","article-title":"dl-3-n-Butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis","volume":"62","author":"Feng","year":"2012","journal-title":"Neuropharmacology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cns.12681","article-title":"n-Butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"23","author":"Zhou","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"B140","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijdevneu.2017.01.003","article-title":"Stem cells for ALS: an overview of possible therapeutic approaches","volume":"57","author":"Czarzasta","year":"2017","journal-title":"Int J Dev Neurosci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s13311-015-0339-9","article-title":"Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis","volume":"12","author":"Goutman","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1574888X10666150902095031","article-title":"Mesenchymal stem cells in the treatment of amyotrophic lateral sclerosis","volume":"11","author":"Hajivalili","year":"2016","journal-title":"Curr Stem Cell Res Ther"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jcyt.2014.02.003","article-title":"Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis","volume":"16","author":"Boido","year":"2014","journal-title":"Cytotherapy"},{"key":"B144","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3727\/096368916X693716","article-title":"Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial","volume":"26","author":"Sykov\u00e1","year":"2017","journal-title":"Cell Transplant"},{"key":"B146","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","article-title":"Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial","volume":"223","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt221","article-title":"Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors","volume":"4","author":"Zhang","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"B148","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.leu.2404489","article-title":"Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth","volume":"21","author":"Ramasamy","year":"2007","journal-title":"Leukemia"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1089\/scd.2010.0157","article-title":"Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus","volume":"20","author":"Horn","year":"2011","journal-title":"Stem Cells Dev"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3727\/096368909X12483162197123","article-title":"Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells","volume":"18","author":"Lopez-Gonzalez","year":"2009","journal-title":"Cell Transplant"},{"key":"B151","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.20901","article-title":"Recovery from paralysis in adult rats using embryonic stem cells","volume":"60","author":"Deshpande","year":"2006","journal-title":"Ann Neurol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/hmg\/ddw163","article-title":"iPSC-derived LewisX+CXCR4+beta1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models","volume":"25","author":"Nizzardo","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B153","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5966\/sctm.2012-0042","article-title":"Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis","volume":"2","author":"Popescu","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.brainres.2015.06.035","article-title":"Neural and glial progenitor transplantation as a neuroprotective strategy for amyotrophic lateral sclerosis (ALS)","volume":"1628","author":"Haidet-Phillips","year":"2015","journal-title":"Brain Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/term.1972","article-title":"Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors","volume":"11","author":"Knippenberg","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e97518","DOI":"10.1371\/journal.pone.0097518","article-title":"Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"B157","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","article-title":"Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice","volume":"3","author":"Kondo","year":"2014","journal-title":"Stem Cell Reports"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e42614","DOI":"10.1371\/journal.pone.0042614","article-title":"Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation","volume":"7","author":"Hefferan","year":"2012","journal-title":"PLoS One"},{"key":"B159","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.21033","article-title":"Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression","volume":"61","author":"Einstein","year":"2007","journal-title":"Ann Neurol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.11.007","article-title":"Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis","volume":"198","author":"Einstein","year":"2006","journal-title":"Exp Neurol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nature03889","article-title":"Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism","volume":"436","author":"Pluchino","year":"2005","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/stem.1199","article-title":"Expression of heme oxygenase-1 in neural stem\/progenitor cells as a potential mechanism to evade host immune response","volume":"30","author":"Bonnamain","year":"2012","journal-title":"Stem Cells"},{"key":"B163","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.expneurol.2008.11.017","article-title":"Neural stem\/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2","volume":"216","author":"Wang","year":"2009","journal-title":"Exp Neurol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.immuni.2011.06.011","article-title":"Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease","volume":"35","author":"Cao","year":"2011","journal-title":"Immunity"},{"key":"B165","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/brain\/awr339","article-title":"Transplanted neural stem\/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord","volume":"135","author":"Cusimano","year":"2012","journal-title":"Brain"},{"key":"B166","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.scr.2013.01.001","article-title":"Human neural stem\/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro","volume":"10","author":"Liu","year":"2013","journal-title":"Stem Cell Res"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/jcmm.12123","article-title":"Interplay between human microglia and neural stem\/progenitor cells in an allogeneic co-culture model","volume":"17","author":"Liu","year":"2013","journal-title":"J Cell Mol Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbi.2016.09.020","article-title":"Induced neural stem cells modulate microglia activation states via CXCL12\/CXCR4 signaling","volume":"59","author":"Gao","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B169","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.0000000000002889","article-title":"Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials","volume":"87","author":"Glass","year":"2016","journal-title":"Neurology"},{"key":"B170","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","article-title":"Human neural stem cell transplantation in ALS: initial results from a phase I trial","volume":"13","author":"Mazzini","year":"2015","journal-title":"J Transl Med"},{"key":"B171","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann Neurol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","article-title":"Intraspinal stem cell transplantation in ALS: a phase I trial, cervical microinjection and final surgical safety outcomes","volume":"74","author":"Riley","year":"2014","journal-title":"Neurosurgery"},{"key":"B173","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1227\/NEU.0b013e31825ca05f","article-title":"Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes","volume":"71","author":"Riley","year":"2012","journal-title":"Neurosurgery"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"key":"B175","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/acn3.134","article-title":"Analysis of graft survival in a trial of stem cell transplant in ALS","volume":"1","author":"Tadesse","year":"2014","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T12:26:41Z","timestamp":1570019201000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":175,"alternative-id":["10.3389\/fimmu.2017.01005"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01005","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"article-number":"1005"}}